|
|
||||||||
Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts
Correspondence: For reprints contact: David Piwnica-Worms, MD, PhD, Dept. of Radiology, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115.
ABSTRACT
Cellular kinetics and binding characteristics of hexakis(carbomethoxyisopropylisonitrile) technetium(I) (Tc-CPI), a new cationic, highly lipophilic myocardial perfusion imaging agent, were evaluated in chick embryo heart cells grown in monolayer culture. Myocytes showed uptake of Tc-CPI to a plateau level with a half-time (t
) of 4.1 ± 0.7 min (mean ± s.e.m.; n = 6); t
appeared independent of extracellular Tc-CPI concentration. Plateau level Tc-CPI uptakes (1016 to 1011 mole Tc-CPI/mg cell protein) were a linear function of extracellular Tc-CPI concentration (range: 1013M to 108M, respectively). Tracer 99mTc-CPI uptake (binding) was not competitively displaced by carrier 99Tc-CPI. Uptake was temperature-sensitive; however, several inhibitors of cationic membrane transport (ouabain, amiloride, bumetanide, and verapamil) showed no significant effect. Extreme alkalinization of external load solution (pHo
8.5) partially inhibited Tc-CPI uptake; however, intracellular pH changes showed no effect. Washout from contractile preparations could be described by a two component system: a fast component (myocytes) with a t
4.5 min and a slow component (fibroblasts) with a t
40 min. Cell fractionation experiments showed most of the activity to be associated with the cell membrane fraction. The data do not demonstrate a specific mechanism for uptake of Tc-CPI; however, results suggest binding to myocytes in a manner proportional to the delivery of the complex to the extracellular spaces. Such properties would be desirable for a myocardial perfusion imaging agent.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |